Newer drugs keep multiple sclerosis patients out of wheelchairs – expert

Chris Bateman


There are fewer multiple sclerosis patients in wheelchairs than ever before in South Africa, mainly due to the advent of interferon drugs over the last decade with better second line drugs over the past three years, says Prof. Girish Modi, Head of Neurology at the University of the Witwatersrand.

Author's affiliations

Chris Bateman, Health and Medical Publishing Group, South Africa

Full Text

PDF (58KB)


Multiple sclerosis; Interferon; New drugs; Physical activity

Cite this article

South African Medical Journal 2016;106(6):543. DOI:10.7196/SAMJ.2016.v106i6.11039

Article History

Date submitted: 2016-05-13
Date published: 2016-05-19

Article Views

Abstract views: 1611
Full text views: 587

Comments on this article

*Read our policy for posting comments here